TY - JOUR
T1 - Circulating microRNA-27a and -133a are negatively associated with incident hypertension
T2 - a five-year longitudinal population-based study
AU - Suzuki, Koji
AU - Yamada, Hiroya
AU - Fujii, Ryosuke
AU - Munetsuna, Eiji
AU - Yamazaki, Mirai
AU - Ando, Yoshitaka
AU - Ohashi, Koji
AU - Ishikawa, Hiroaki
AU - Mizuno, Genki
AU - Tsuboi, Yohiski
AU - Hashimoto, Shuji
AU - Hamajima, Nobuyuki
N1 - Funding Information:
This work was supported by JSPS KAKENHI [Grant Numbers JP 26293144, JP17K09139, JP16H06277, and JP20K10515]. We thank all the study participants and staff involved in the health examinations conducted in Yakumo, Hokkaido, Japan.
Publisher Copyright:
© 2022 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Background: Previous cross-sectional studies have shown that several circulating microRNA levels are associated with hypertension, but there are no prospective studies among general populations. Objective: We evaluated the impact of circulating inflammatory- and oxidative stress-responsive microRNAs on changes in blood pressure and the development of hypertension in normotensive Japanese. Method: The study subjects were 84 normotensive participants (33 men and 51 women) who were given a health examination in both 2012 and 2017. In five years, 29 participants developed hypertension. Serum levels of miRNAs (miR-21, miR-27a, and miR-133a) were measured using qRT-PCR. Odds ratios (ORs) and 95% confidence intervals (CIs) for incident hypertension were estimated by logistic regression analysis. Results: Serum miR-27a and -133a levels were lower in newly hypertensive subjects compared with normotensive subjects. With 1-unit lower serum miR-27a and -133a, the confounders adjusted ORs and 95% CI for incident hypertension were 0.84 (0.72–0.96) and 0.75 (0.58–0.91), respectively. The group with high levels of serum miR-27a and -133a had lower ORs than the group with low levels of these miRNAs (OR and 95% CI of miR-27a: 0.29, 0.08–0.91; miR-133a: 0.08, 0.01–0.37, respectively). Conclusions: Circulating miR-27a and -133a are potential biomarkers for the prediction and prevention of hypertension.
AB - Background: Previous cross-sectional studies have shown that several circulating microRNA levels are associated with hypertension, but there are no prospective studies among general populations. Objective: We evaluated the impact of circulating inflammatory- and oxidative stress-responsive microRNAs on changes in blood pressure and the development of hypertension in normotensive Japanese. Method: The study subjects were 84 normotensive participants (33 men and 51 women) who were given a health examination in both 2012 and 2017. In five years, 29 participants developed hypertension. Serum levels of miRNAs (miR-21, miR-27a, and miR-133a) were measured using qRT-PCR. Odds ratios (ORs) and 95% confidence intervals (CIs) for incident hypertension were estimated by logistic regression analysis. Results: Serum miR-27a and -133a levels were lower in newly hypertensive subjects compared with normotensive subjects. With 1-unit lower serum miR-27a and -133a, the confounders adjusted ORs and 95% CI for incident hypertension were 0.84 (0.72–0.96) and 0.75 (0.58–0.91), respectively. The group with high levels of serum miR-27a and -133a had lower ORs than the group with low levels of these miRNAs (OR and 95% CI of miR-27a: 0.29, 0.08–0.91; miR-133a: 0.08, 0.01–0.37, respectively). Conclusions: Circulating miR-27a and -133a are potential biomarkers for the prediction and prevention of hypertension.
UR - http://www.scopus.com/inward/record.url?scp=85132651583&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132651583&partnerID=8YFLogxK
U2 - 10.1080/1354750X.2022.2070281
DO - 10.1080/1354750X.2022.2070281
M3 - Article
C2 - 35465807
AN - SCOPUS:85132651583
VL - 27
SP - 496
EP - 502
JO - Biomarkers
JF - Biomarkers
SN - 1354-750X
IS - 5
ER -